# DPP-4 Inhibitors

DPP-4 inhibitors are oral medications that enhance the activity of incretin hormones, leading to increased insulin secretion and reduced glucagon levels.

They are generally well tolerated and have a low risk of hypoglycemia.

## Clinical Use
- Used in Type 2 diabetes
- Suitable for patients intolerant to other oral agents
- Can be used as monotherapy or combination therapy

## Examples
- Linagliptin
- Sitagliptin
